Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action. - Test2 - elhamkhani - TriplyDB

Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action.

Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action.

http://www.wikidata.org/entity/Q38974266

about

Matricellular proteins: a sticky affair with cancers Expression of Pentraxin 3 and Thrombospondin 1 in Gingival Crevicular Fluid during Wound Healing after Gingivectomy in Postorthodontic Patients.Thrombospondin-1 is a putative target gene of Runx2 and Runx3.Expression and localization of members of the thrombospondin family during final follicle maturation and corpus luteum formation and function in the bovine ovary.Perindopril Induces TSP-1 Expression in Hypertensive Patients with Endothelial Dysfunction in Chronic Treatment.Thrombospondins: A Role in Cardiovascular Disease.Functions and transcriptional regulation of thrombospondins and their interrelationship with fibroblast growth factor-2 in bovine luteal cells.Predictive model identifies strategies to enhance TSP1-mediated apoptosis signaling.Localization of thrombospondin-1 and its receptor CD36 in the ovary of the ostrich (Struthio camelus).Human expression patterns: qualitative and quantitative analysis of thrombospondin-1 under physiological and pathological conditions.Involvement of TSP1 and MMP9/NGAL in angiogenesis during orthodontic periodontal remodeling

P2860

Q21296660-B9104EFE-DEDD-46C8-9835-CDFDE57C344E Q37043994-90759016-25D3-49C5-A1E2-F04DB4A9F0F3 Q37091945-09628D74-A9DF-4BF1-A3C4-5E0E8B47CF93 Q37369734-281621B9-96C6-4776-B11D-611C9FFCEC67 Q37690844-A9F11E52-DC40-4112-8A6D-608C00D0D23F Q39438819-0145D29C-1240-45A4-B4DE-FCB2C2F1EE22 Q42462905-6A6BF529-E525-4C36-AEE4-8670BD55D886 Q47234112-E248AE59-BF6E-4283-8472-04679F8CDE89 Q47368029-5A6BE517-3885-4EE7-9254-C37EA72C5F3B Q50019794-E8760AA5-1C0B-4EEB-A5CA-A14AC6A41811 Q59075750-D7BD5F88-2178-4B83-BB3E-95C154B6F0F7

P2860

Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action.

http://www.wikidata.org/entity/Q38974266

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Thrombospondin-1 as a Paradigm ...... Multiple Mechanisms of Action.

@en

type

label

Thrombospondin-1 as a Paradigm ...... Multiple Mechanisms of Action.

@en

prefLabel

Thrombospondin-1 as a Paradigm ...... Multiple Mechanisms of Action.

@en

P1433

Q38974266-CA4C6CB8-6075-47DC-B6C5-5123BE4F0D8A

P1476

Q38974266-AF00D1A6-963E-4A9A-8D10-25F788207DE7

P2093

Q38974266-55762570-E2B7-4882-AEF7-22083F2334CA

Q38974266-6AF38C2D-C304-4F2B-922B-E38FE6B0B5A5

P2860

Q38974266-01B09C83-66EC-4A4C-AD11-7C82CFF21BB1

Q38974266-01CFC146-0C83-468C-98F0-ED248881FAAD

Q38974266-053437EA-A88D-4147-ABE2-EF1577332D3F

Q38974266-057CEE4E-0E0F-41D5-9A48-3F54CD4D6C60

Q38974266-059ED17B-E7C3-4C22-B86D-D381E327534A

Q38974266-0600EA70-A71B-44DC-8EB7-1DAFF8F645CB

Q38974266-060C6D43-6E66-4F56-9E72-A75938A55173

Q38974266-0683E261-9AD7-4A06-8384-5282E7A36E5F

Q38974266-077A9853-316E-4AD5-8673-AE9148202BE3

Q38974266-08702BCB-2356-4518-B1CE-460153608170

P304

Q38974266-5BCB526D-DF36-43F3-86DE-3AC4B69D7993

P31

Q38974266-29DB4E8A-C9AA-4928-B5C5-317723CEAC62

P356

Q38974266-ABEEB9FC-82C5-4768-8963-7803928DEEEB

P433

Q38974266-2918F234-E81E-4ABD-B6B6-5D9BB7DF12E2

P478

Q38974266-CE050EBF-F14F-4E95-BA73-DC3A48A3237A

P50

Q38974266-038EDFD7-34EF-4350-9B18-5F07B6AC5353

Q38974266-4260CB9B-FD04-4716-93B0-4E61783DDF4F

Q38974266-5CD28FF9-CD77-4B8C-836D-DFCC6773C7B3

P577

Q38974266-01CA2388-011C-49AA-B7E0-38BD3C5ECC31

P5875

Q38974266-CEE1B8D1-5D2E-409D-BC33-0543DEC5480E

P698

Q38974266-E7F3799A-E18C-4317-8235-8D9F0490F888

P932

Q38974266-B0FA275D-86D3-42E5-8353-126AFAABE105

P356

P1433

Pharmaceuticals

P1476

Thrombospondin-1 as a Paradigm ...... Multiple Mechanisms of Action

@en

P2093

Chiara Urbinati

http://www.w3.org/2001/XMLSchema#string

Silvia Bonifacio

http://www.w3.org/2001/XMLSchema#string

P2860

First-in-class, first-in-human phase I results of targeted agents: highlights of the 2008 American society of clinical oncology meeting

Involvement of alpha-2-macroglobulin receptor in clearance of interleukin 8-alpha-2-macroglobulin complexes by human alveolar macrophages

The chemokine CXCL13 (BCA-1) inhibits FGF-2 effects on endothelial cells

Syndecan-4 contributes to endothelial tubulogenesis through interactions with two motifs inside the pro-angiogenic N-terminal domain of thrombospondin-1

Insulin-like growth factor binding protein-5 (IGFBP-5) interacts with thrombospondin-1 to induce negative regulatory effects on IGF-I actions

Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain

Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator

Interactions of thrombospondin with extracellular matrix proteins: selective binding to type V collagen

Interaction of alpha9beta1 integrin with thrombospondin-1 promotes angiogenesis

Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells

P304

1241-1278

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/PH3041241

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Giulia Taraboletti

P577

2010-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43336203

http://www.w3.org/2001/XMLSchema#string

P698

27713299

http://www.w3.org/2001/XMLSchema#string

P932

4034032

http://www.w3.org/2001/XMLSchema#string